Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.8.0.1
RELATED PARTY TRANSACTIONS (Details Narrative)
 1 Months Ended 12 Months Ended 19 Months Ended
Jun. 19, 2017
USD ($)
Apr. 02, 2017
USD ($)
shares
Mar. 21, 2017
USD ($)
Investor
Mar. 20, 2017
USD ($)
$ / shares
shares
Mar. 03, 2017
USD ($)
$ / shares
shares
Mar. 01, 2017
USD ($)
Feb. 10, 2017
USD ($)
Dec. 29, 2016
USD ($)
shares
Nov. 30, 2016
USD ($)
$ / shares
shares
Sep. 21, 2016
USD ($)
$ / shares
shares
Sep. 06, 2015
USD ($)
shares
Aug. 07, 2017
USD ($)
Mar. 21, 2017
USD ($)
Investor
shares
Dec. 29, 2016
USD ($)
Sep. 30, 2017
USD ($)
$ / shares
shares
Sep. 30, 2016
USD ($)
Feb. 28, 2017
USD ($)
Sep. 16, 2016
Investor
Aug. 16, 2016
USD ($)
Accrued interest                               $ 317,000      
Number of shares converted | shares                             1,073,531        
Principal investment in convertible notes                             $ 5,300,000        
Interest                             267,600        
Capital contribution paid                             $ 190,000      
Master Purchase and Option Agreement [Member] | Arcadian Telepsychiatry LLC & Mr. Mr. Robert Plotkin [Member]                                      
Percentage of equity investment   10.00%                         19.00%        
Capital contribution paid $ 20,000 $ 100,000                   $ 70,000              
Master Purchase and Option Agreement [Member] | Mr. Mr. Robert Plotkin [Member]                                      
Number of common stock issued | shares   1,000                                  
Four Accredited Investors [Member]                                      
Number of shares converted | shares                     42,084                
Principal investment in convertible notes                     $ 200,000                
Interest                     $ 10,400                
Four Accredited Investors [Member] | Private Placement [Member]                                      
Number of accredited investors | Investor     4                   4            
Number of common stock issued | shares                         237,000            
Proceeds from issuance of private placement                         $ 1,481,300            
RSJ (Michal Votruba) [Member]                                      
Number of shares converted | shares [1]                             444,454        
Principal investment in convertible notes [1]                             $ 2,100,000        
Interest [1]                             $ 122,200        
RSJ (Michal Votruba) [Member] | Subscription Agreement [Member]                                      
Share price (in dollars per share) | $ / shares       $ 6.25                              
Number of common stock issued | shares       160,000                              
Proceeds from issuance of private placement       $ 1,000,000                              
John Pappajohn [Member]                                      
Number of accredited investors | Investor                                   4  
Number of shares converted | shares [2]                             290,498        
Principal investment in convertible notes [2]                             $ 1,600,000        
Interest [2]                             $ 52,500        
John Pappajohn [Member] | Private Placement [Member]                                      
Share price (in dollars per share) | $ / shares                             $ 6.25        
Number of common stock issued | shares               16,000 32,000       72,000   120,000        
Proceeds from issuance of private placement     $ 250,000       $ 200,000 $ 100,000 $ 200,000       $ 450,000 $ 100,000 $ 750,000        
Thomas Tierney (Tierney Family Trust) [Member]                                      
Number of shares converted | shares [3]                             137,328        
Principal investment in convertible notes [3]                             $ 640,000        
Interest [3]                             $ 46,600        
Thomas Tierney (Tierney Family Trust) [Member] | Private Placement [Member]                                      
Share price (in dollars per share) | $ / shares                 $ 6.25                    
Number of common stock issued | shares                 32,000                    
Proceeds from issuance of private placement                 $ 200,000                    
Mr. Robin L. Smith, M.D [Member]                                      
Number of shares converted | shares [4]                             20,776        
Principal investment in convertible notes [4]                             $ 100,000        
Interest [4]                             $ 3,900        
Mr. Robin L. Smith, M.D [Member] | Private Placement [Member]                                      
Share price (in dollars per share) | $ / shares                 $ 6.25                    
Number of common stock issued | shares                 16,000                    
Proceeds from issuance of private placement                 $ 100,000                    
Geoffrey E. Harris [Member]                                      
Number of shares converted | shares [5]                             2,058        
Principal investment in convertible notes [5]                             $ 10,000        
Interest [5]                             300        
Geoffrey E. Harris [Member] | Private Placement [Member]                                      
Share price (in dollars per share) | $ / shares         $ 6.25                            
Number of common stock issued | shares         5,000               5,000            
Proceeds from issuance of private placement         $ 31,250               $ 31,300            
Decision Calculus Associates (Jill Carpenter) [Member] | Marketing Services Consulting Agreement [Member]                                      
Marketing expense paid per month           $ 3,000                     $ 10,000    
Marketing expense paid                             71,000 120,000      
John Pappajohn [Member] | Hooper Holmes Agreement [Member]                                      
Professional fees                             20,300 $ 0      
Mr. Plotkin[Member] | Arcadian Telepsychiatry LLC & Mr. Mr. Robert Plotkin [Member]                                      
Principal investment in convertible notes                             $ 297,000        
Convertible Notes [Member]                                      
Aggregate principal amount                                     $ 6,000,000
Conversion price (in dollars per share) | $ / shares                   $ 5.00                  
Accrued interest                                     $ 317,000
Number of shares converted | shares                   1,263,406                  
Convertible Notes [Member] | Directors and Officer [Member]                                      
Aggregate principal amount                   $ 5,300,000                  
[1] RSJ PE is a greater than 10% shareholder. Michal Votruba, a Director for Life Sciences for the RSJ/Gradus Fund, joined our Board on July 30, 2015.
[2] John Pappajohn is a member of the Board. He purchased $1,600,000 of Notes of which $200,000 were assigned to four accredited investors on September 6, 2015. Approximately $10,400 of the total interest was attributable to such transferred Notes, resulting in an aggregate of 42,084 shares being issued upon the conversion of such transferred Notes.
[3] Thomas Tierney is a trustee of the Tierney Family Trust. Mr. Tierney was a member of our Board between September 2016 and July 2017, and prior to that, between February 2013 and May 2015. The Tierney Family Trust is a greater than 5% shareholder of the Company.
[4] Dr. Robin Smith is the Chairman of the Board.
[5] Geoffrey Harris is a member of the Board and Chairman of the Audit Committee.